Alembic Pharmaceuticals
APLLTD
₹ 1,053.70
- ₹ 64.44
5.76%
Healthcare
₹ 0.00
(%)1D
Updated: 22 Oct 2024, 03:32:16 pm IST
Stock Score
Open Price
₹ 1,110.75
Prev. Close
₹ 1,118.14
₹ 1,046.56
Day Low
₹ 1,124.91
Day High
₹ 679.00
52 Week Low
₹ 1,392.80
52 Week High
Quick Bite
Price To Earnings Ratio 33.63 | Sector PE 59.59 |
PB Ratio 4.30 | Sector PB 8.75 |
EPS 31.33 | Dividend Yield 1.12 |
Today's Volume 227.172 K | 5 Day Avg. Volume 183.900 K |
PEG Ratio 0.42 | Market Cap. ₹ 22,810.00 Cr. |
Returns Comparison
| Time | APLLTD | VS | Industry |
|---|---|---|---|
| 1 Day | -5.76% | -3.22% | |
| 1 Week | -7.65% | -5.8% | |
| 1 Month | -2.81% | -4.68% | |
| 6 Months | 5.38% | 16.04% | |
| 1 Year | 31.01% | 50.81% |
Technical Trend
Bearish
Bearish
Neutral
Bullish
Pivot Levels
R3 ₹ 1,181.90
R2 ₹ 1,153.41
R1 ₹ 1,103.55
RESISTANCE
₹ 1,075.06
SUPPORT
S1 ₹ 1,025.20
S2 ₹ 996.71
S3 ₹ 946.85
Moving Averages
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
6
Buy
0
| Period (Days) | SMA | Indication |
|---|---|---|
| 10 | 1136.99 | Bearish |
| 20 | 1164.96 | Bearish |
| 30 | 1167.34 | Bearish |
| 50 | 1131.3 | Bearish |
| 100 | 1093.71 | Bearish |
| 200 | 1057.41 | Bearish |
News & Events
Alembic Pharma gets USFDA approval for Diltiazem Hydrochloride Extended-Release Capsules
USFDA completes inspection at Alembic Pharmaceuticals’ Oncology formulation facility
Alembic Pharmaceuticals gets final nod for Alcaftadine Ophthalmic Solution
Alembic Pharmaceuticals gets USFDA’s final approval for Lamotrigine Extended-Release Tablets
Shareholding Updates
69.61%
Promoters
Sep 2024
Promoters 69.61%
FII 3.94%
DII 16.05%
Public 10.4%
Others 0%
Cash Flow
| Annual | FY 2024 | FY 2023 | FY 2022 | ||||
|---|---|---|---|---|---|---|---|
| Operating Activities | 803.21 | 723.94 | 552.35 | ||||
| Investing Activities | -320.61 | -447.59 | -371.97 | ||||
| Financing Activities | -437.87 | -261.96 | -217.35 | ||||
| Net Cash Flow | 44.73 | 14.39 | -36.97 |
All Figures in ₹ Cr., unless mentioned otherwise
Ratios
Return on Equity (%)
Income Statement
All Figures in ₹ Cr., unless mentioned otherwise
Balance Sheet
All Figures in ₹ Cr., unless mentioned otherwise
Peer Comparison
| Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
|---|---|---|---|---|---|
| Alembic Pharmaceuticals | -5.76 | -7.65 | -2.81 | 5.38 | 31.01 |
| Alembic | -3.07 | -13.09 | -16.04 | -10 | -10 |
| Aurobindo Pharma | -0.97 | -2.16 | -2.84 | 24.09 | 54.91 |
| Fortis Healthcare | -2.55 | -5.38 | -3.01 | 23.62 | 74.56 |
| Ajanta Pharmaceuticals | -6.64 | -11.6 | -5.55 | 30.65 | 61.04 |
Returns as on 22 Oct, 2024
About Alembic Pharmaceuticals
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.
Alembic Pharmaceuticals FAQs
How to Buy Alembic Pharmaceuticals Share?
To purchase Alembic Pharmaceuticals shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Alembic Pharmaceuticals (ticker symbol: APLLTD) on the trading platform provided by your broker and purchase the shares.
What's Alembic Pharmaceuticals share price today?
The stock price of Alembic Pharmaceuticals as of 22 Oct 2024 is ₹1,053.70
What is the Market Cap of Alembic Pharmaceuticals?
Market capitalisation represents the total market value of a company's outstanding shares. As of 22 Oct 2024, Alembic Pharmaceuticals (ticker symbol: APLLTD) has a market capitalisation of approximately ₹2,28,10,00,00,000.00
What is the PE and PB ratio of Alembic Pharmaceuticals?
Alembic Pharmaceuticals Ltd's price-to-book ratio as of 22 Oct 2024 is 4.3, reflecting the market's valuation compared to its asset value. As of 22 Oct 2024, the trailing twelve months P/E (price-to-earnings) ratio is 33.63, indicating the market values the company at around ₹33.63 for every ₹1 of earnings
What is the 52 Week High and Low of Alembic Pharmaceuticals Share?
Alembic Pharmaceuticals Ltd (APLLTD) hit its 52-week high at ₹1,392.80, and its 52-week low at ₹679.00.
Want to learn and earn in Stocks?